Home/Filings/4/0001415889-22-001731
4//SEC Filing

Calamari Christopher J. 4

Accession 0001415889-22-001731

CIK 0000001800other

Filed

Feb 22, 7:00 PM ET

Accepted

Feb 23, 8:02 PM ET

Size

9.0 KB

Accession

0001415889-22-001731

Insider Transaction Report

Form 4
Period: 2022-02-18
Calamari Christopher J.
SENIOR VICE PRESIDENT
Transactions
  • Award

    Option (right to buy)

    2022-02-18+59,70859,708 total
    Exercise: $117.58From: 2023-02-18Exp: 2032-02-17Common Shares (59,708 underlying)
  • Award

    Common shares without par value

    2022-02-18+12,81228,732 total
Holdings
  • Common shares without par value

    (indirect: By Trust)
    30,193
  • Common shares without par value

    (indirect: By Trust)
    101
Footnotes (3)
  • [F1]These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes.
  • [F2]Balance in the Abbott Laboratories Stock Retirement Trust as of February 18, 2022.
  • [F3]Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 19,902 on February 18, 2023, 19,903 on February 18, 2024 and 19,903 on February 18, 2025.

Issuer

ABBOTT LABORATORIES

CIK 0000001800

Entity typeother

Related Parties

1
  • filerCIK 0001868518

Filing Metadata

Form type
4
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 8:02 PM ET
Size
9.0 KB